Publications by authors named "James Reimann"

Claim this Profile
I
Impact of exploratory biomarkers on the treatment effect of bevacizumab in metastatic breast cancer.
Adrian M Jubb, Kathy D Miller, Hope S Rugo, Adrian L Harris, Dafeng Chen, James D Reimann

Clin Cancer Res· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allergen skin tests and free IgE levels during reduction and cessation of omalizumab therapy.
Jonathan Corren, Gail Shapiro, James Reimann, Yamo Deniz, Dennis Wong

J Allergy Clin Immunol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concordance between central and local laboratory HER2 testing from a community-based clinical study.
Josina C Reddy, James D Reimann, Steven M Anderson, Pamela M Klein

Clin Breast Cancer· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration.
Philip J Rosenfeld, Steven D Schwartz, Mark S Blumenkranz, Joan W Miller, Julia A Haller, James D Reimann

Ophthalmology· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer.
Kathy D Miller, Linnea I Chap, Frankie A Holmes, Melody A Cobleigh, P Kelly Marcom, James D Reimann

J Clin Oncol· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of omalizumab, a humanized monoclonal anti-IgE antibody, on nasal reactivity to allergen and local IgE synthesis.
Jonathan Corren, David Diaz-Sanchez, Andrew Saxon, Yamo Deniz, James Reimann

Ann Allergy Asthma Immunol· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer.
Melody A Cobleigh, Virginia K Langmuir, George W Sledge, Kathy D Miller, Latrice Haney, James D Reimann

Semin Oncol· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis